Navigation Links
Avanir Pharmaceuticals Reports Fiscal 2013 First Quarter Financial And Business Results
Date:2/7/2013

f emotional lability that can commonly occur, for example, in Alzheimer's disease and other dementias.

NUEDEXTA and certain other medicines can interact, causing serious side effects. If you take certain drugs or have certain heart problems, NUEDEXTA may not be right for you.

NUEDEXTA causes dose-dependent QTc prolongation. When initiating NUEDEXTA in patients at risk for QT prolongation and torsades de pointes, electrocardiographic (ECG) evaluation should be conducted at baseline and 3-4 hours after the first dose.

The most common adverse reactions are diarrhea, dizziness, cough, vomiting, asthenia, peripheral edema, urinary tract infection, influenza, increased gamma-glutamyltransferase, and flatulence. NUEDEXTA may cause dizziness.

These are not all the risks from use of NUEDEXTA. Please refer to full Prescribing Information at www.NUEDEXTA.com.

About Avanir Pharmaceuticals, Inc.Avanir Pharmaceuticals, Inc. is a biopharmaceutical company focused on bringing innovative medicines to patients with central nervous system disorders of high unmet medical need. As part of our commitment, we have extensively invested in our pipeline and are dedicated to advancing medicines that can substantially improve the lives of patients and their loved ones. For more information about Avanir, please visit www.avanir.com.

Avanir® and NUEDEXTA® are registered trademarks owned by Avanir Pharmaceuticals, Inc.

©2013 Avanir Pharmaceuticals, Inc. All Rights Reserved.

Forward Looking StatementsExcept for the historical information contained herein, the matters set forth in this press release, including statements regarding Avanir's plans, potential opportunities, financial or other expectations, projections, goals objectives, milestones, strategies, market growth, timelines, legal matters, product pipeline, clinical studies, pro
'/>"/>

SOURCE Avanir Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Avanir Pharmaceuticals To Present at Three Conferences In May
2. Avanir Pharmaceuticals Announces Date Of Fiscal 2012 Second Quarter Financial Results And Conference Call
3. Avanir Pharmaceuticals to Present at Jefferies 2012 Global Healthcare Conference
4. Avanir Pharmaceuticals Announces Date Of Fiscal 2012 Third Quarter Financial Results And Conference Call
5. Avanir Pharmaceuticals To Present At Two Investor Conferences In August
6. Avanir Pharmaceuticals Announces Enrollment Of First Patient In Study Of AVP-923 For The Treatment Of Agitation In Patients With Alzheimers Disease
7. Avanir Pharmaceuticals Announces Publication Of PBA Burden Of Illness Study
8. Avanir Pharmaceuticals To Present At UBS Global Life Sciences Conference
9. Avanir Pharmaceuticals Achieves Commercial Milestones & Provides Clinical Updates
10. Avanir Pharmaceuticals To Present At 24th Annual Piper Jaffray Healthcare Conference
11. Avanir Pharmaceuticals Pre-Announces Preliminary Fiscal 2012 Fourth Quarter Results And Provides Clinical Study Update
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/26/2014)... 2014  Kewaunee Scientific Corporation (Nasdaq: KEQU ... July 31, 2014. Sales for the quarter ... the first quarter last year. Net earnings for the ... compared to net earnings of $1,587,000, or $0.61 per ... year. However, both sales and earnings in the first ...
(Date:8/26/2014)... YORK , Aug. 26, 2014 /PRNewswire/ ... research report is available in its catalogue: ... Outlook to 2020 ... Gastroscopes Market Outlook to 2020 Summary ... Gastroscopes Market Outlook to 2020", provides key ...
(Date:8/26/2014)... Del. , Aug. 26, 2014 Biomedical ... it has been named to the prestigious 2014 Inc. ... are honored to be included on this prestigious list ... said Chris Jacob , Biomedical Research Laboratories, CEO. ... and further serves to validate the hard work and ...
Breaking Medicine Technology:Kewaunee Scientific Reports Results for First Quarter 2Kewaunee Scientific Reports Results for First Quarter 3Kewaunee Scientific Reports Results for First Quarter 4Kewaunee Scientific Reports Results for First Quarter 5Kewaunee Scientific Reports Results for First Quarter 6Japan Esophagoscopes & Gastroscopes Market Outlook to 2020 2Japan Esophagoscopes & Gastroscopes Market Outlook to 2020 3Japan Esophagoscopes & Gastroscopes Market Outlook to 2020 4Japan Esophagoscopes & Gastroscopes Market Outlook to 2020 5Biomedical Research Laboratories Named to Inc. 500 List of America's Fastest-Growing Companies 2
... YORK, Oct. 18, 2011 Reportlinker.com announces ... available in its catalogue: ... to 2020 http://www.reportlinker.com/p0657234/Cervarix-Cervical-Cancer---Analysis-and-Forecasts-to-2020.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Pathology ... Analysis and Forecasts to 2020 ...
... Reportlinker.com announces that a new market research ... Orthopedic Biomaterials, The World Market ... products, which can be organic or synthetic in ... fracture to facilitate healing or to compensate for ...
Cached Medicine Technology:Cervarix (Cervical Cancer) - Analysis and Forecasts to 2020 2Cervarix (Cervical Cancer) - Analysis and Forecasts to 2020 3Cervarix (Cervical Cancer) - Analysis and Forecasts to 2020 4Orthopedic Biomaterials, The World Market 2Orthopedic Biomaterials, The World Market 3Orthopedic Biomaterials, The World Market 4
(Date:8/27/2014)... Aspirus Wausau Hospital today announced the ... Buzz™ Digital O.R. at Aspirus Wausau Hospital, in Wausau, ... operating rooms will be Buzz, a centralized surgical hub ... supports planning, navigation, imaging and communications connectivity. , ... software and hardware all controlled from the full HD ...
(Date:8/27/2014)... 2014 BCC Research ( http://www.bccresearch.com ) ... IMPLANTS AND REGENERATIVE PRODUCTS , the global market for ... billion by 2014-end to $42.2 billion by 2019, with ... 2014 to 2019. New technologies and an increasingly older ... the market. , While there are many conventional and ...
(Date:8/27/2014)... (PRWEB) August 27, 2014 UNIWIGS, one of the ... hair pieces, offers big deals and sales on all its products, ... hair products can save much on UniWigs hair products ... orders, they can save $10 with a coupon code LABOR10; while ... a coupon code LABOR50. Besides this deal which coupon code is ...
(Date:8/27/2014)... HealthDay Reporter TUESDAY, Aug. 26, 2014 ... for blood transfusions might also protect the brains of premature ... stimulates red blood cell production, appears to prevent brain damage ... Petra Huppi, a professor of pediatrics and newborn medicine at ... of whether EPO protects the brains of these children will ...
(Date:8/27/2014)... Hepatocellular carcinoma (HCC) is the second leading cause ... are due to the difficulty in treating this ... epirubicin, cisplatin, 5-fluorouracil, etoposide or combinations therein. This ... are not able to reach in a sufficient ... that are not harmful to the rest of ...
Breaking Medicine News(10 mins):Health News:Aspirus Wausau Hospital Announces First Large Scale Digital Operating Room Integration Project in the US 2Health News:Aspirus Wausau Hospital Announces First Large Scale Digital Operating Room Integration Project in the US 3Health News:Global Market for Advanced Orthopedic Technology to Reach $42.2 Billion in 2019; Biotechnological Advancements Driving the Market 2Health News:Global Market for Advanced Orthopedic Technology to Reach $42.2 Billion in 2019; Biotechnological Advancements Driving the Market 3Health News:UniWigs Is Offering A Big Sale for Labor Day on All Its Products 2Health News:Hormone Might Help Preemies' Brains 2Health News:Hormone Might Help Preemies' Brains 3Health News:The thunder god vine, assisted by nanotechnology, could shake up future cancer treatment 2Health News:The thunder god vine, assisted by nanotechnology, could shake up future cancer treatment 3
... , it could be causing gut inflammation, study suggests, , ... in the mouth, skin and intestines might play a role ... study says. , Researchers found the bacterium ... all babies in their study who had colic, a condition ...
... N.J., Aug. 6 Vitamin Shoppe Industries Inc., a leading ... products, will hold a conference call for its bondholders on ... the call, members of management will report on the Company,s ... To participate in the teleconference, bondholders are invited to ...
... , , Truth-teller Wendell Potter Asks ... SANTA MONICA, Calif., Aug. 6 The following is being released ... public messages to federal Office of Reform chief Nancy Ann DeParle, insurance ... Angeles stadium next week where medical volunteers will offer health care services ...
... Preventive measures urgently needed, researcher says , THURSDAY, Aug. 6 ... bone fracture is doubled for people who have a stroke, ... need for immediate preventive action after a stroke, said Frank ... of Utrecht, and lead author of a report that appears ...
... Experiment shows that these birds can use tools to solve problems ... shows. , A U.K. study found that the members of the ... of water in a container to bring a floating worm within ... study showed a high degree of accuracy, using only the exact ...
... , PHOENIX, Aug. 6 NutraCea ... bran nutrient research and technology, today announced the Company has entered ... Fargo") relating to the previously disclosed "Events of Default" which accelerated ... 18, 2008. , , Pursuant to the ...
Cached Medicine News:Health News:Bacteria May Be Connected to Colic 2Health News:Health Insurance Whistleblower Urges Obama Health Chiefs to Join Him at Free Urban Health Care 'Expedition' in L.A. Stadium 2Health News:Health Insurance Whistleblower Urges Obama Health Chiefs to Join Him at Free Urban Health Care 'Expedition' in L.A. Stadium 3Health News:Health Insurance Whistleblower Urges Obama Health Chiefs to Join Him at Free Urban Health Care 'Expedition' in L.A. Stadium 4Health News:Health Insurance Whistleblower Urges Obama Health Chiefs to Join Him at Free Urban Health Care 'Expedition' in L.A. Stadium 5Health News:Health Insurance Whistleblower Urges Obama Health Chiefs to Join Him at Free Urban Health Care 'Expedition' in L.A. Stadium 6Health News:Stroke Doubles Risk of Hip, Thigh Fractures 2Health News:Stroke Doubles Risk of Hip, Thigh Fractures 3Health News:Rooks Show Intelligence in Catching the Worm 2Health News:NutraCea Announces Forbearance Agreement With Bank and Provides Update on Business Strategy and Transactions 2Health News:NutraCea Announces Forbearance Agreement With Bank and Provides Update on Business Strategy and Transactions 3Health News:NutraCea Announces Forbearance Agreement With Bank and Provides Update on Business Strategy and Transactions 4Health News:NutraCea Announces Forbearance Agreement With Bank and Provides Update on Business Strategy and Transactions 5
... Cascade M-4 is a manual ... all routine clotting assays - PTs, ... Designed for easy, inexpensive, low-volume testing, ... but big on features, offering time ...
... a fully automated, benchtop coagulation workstation ... immunological assays in true random access ... sample management offers high throughput and ... the need to interrupt current testing. ...
The CA-50 is a compact semi-automated coagulation analyzerproviding 4-parameter random access....
... The ACL 100 is an ... workloads, or as a backup ... runs clotting assays, such as ... it's backed by superior technology ...
Medicine Products: